Letermovir vs Valganciclovir in CMV R+ Kidney Transplant

NCT07571135 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

OTHER_GOV

Sponsor class

Conditions

CMV Infection
CMV
CMV Viremia
CMV Disease

Interventions

DRUG: Letermovir
DRUG: Valganciclovir CMV Prophylaxis

Sponsor

Elisabeth Kincaide